Jabra Enhance Plus vs Resound Vivia 9 60S microRIE

The Jabra Enhance Plus is a mid-priced OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This visible-in-ear device ranks #28 of 65 OTC hearing aids tested, placing it in the top 42% of its category. In our testing, the Enhance Plus demonstrated notable strengths in speech clarity and audio streaming. Speech in quiet scored a strong 4.2/5, measuring 1.36 points above the category average. Music streaming performance was equally impressive at 3.8/5, a full 1.88 points above average—making this a solid choice for users who prioritize phone audio streaming. Feedback handling was excellent at 4.7/5. However, the device has a significant weakness: own-voice comfort scored just 0.3/5, falling 2.21 points below the category average. This suggests pronounced occlusion effects that may make the user's own voice sound boomy or unnatural. Speech in noise performance was mixed at 2.1/5—above the category average by 0.62 points, but still limited in absolute terms for challenging listening environments. The Enhance Plus showed meaningful improvement with tuning, jumping from a normalized Initial Score of 3.6/5 to a Tuned Score of 4.2/5. Buyers should note that several competitors in the same price range score higher, including the Sony CRE-E10 at 4.66/5. This device is best suited for users who prioritize music streaming and speech clarity in quieter settings, and who can tolerate own-voice occlusion.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.